Eric B. Kmiec - Founder and Chief Scientific Officer @ CorriXR Therapeutics

Start Free Trial

Pricing

Overview

Number of Founded Organizations

CB Rank (Person)

530,063

Primary Job Title Founder and Chief Scientific Officer
Primary Organization
CorriXR Therapeutics

Location Newark, Delaware, United States
Regions Greater Philadelphia Area, East Coast, Southern US
Gender Male

LinkedIn View on LinkedIn

Eric B. Kmiec is the Founder and Chief Scientific Officer of CorriXR Therapeutics. He previously worked at Delaware State University as a Professor and Chairman of the Chemistry Department. Eric B. Kmiec attended the University of Florida.

Jobs

Number of Current Jobs

Number of Past Jobs

Eric B. Kmiec

has

current jobs including

Founder and Chief Scientific Officer

CorriXR Therapeutics

Editor in Chief, Gene and Genome Editing

Elsevier

, and

Executive Director & Chief Scientific Officer, Gene Editing Institute

Christiana Care Health Systems

. Additionally,

Eric B. Kmiec

has had

past job as the

Co-founder, Chief Scientific Officer and Board Member

Orphagenix

CorriXR Therapeutics Founder and Chief Scientific OfficerSep 2023
Elsevier Editor in Chief, Gene and Genome EditingJul 2023
Christiana Care Health Systems Executive Director & Chief Scientific Officer, Gene Editing Institute2022
University of Delaware Affiliated Faculty, College of Health Sciences2015

Organization Name	Title At Company	Start Date	End Date
Orphagenix	Co-founder, Chief Scientific Officer and Board Member	2005	2013

Related Hubs

Hub Name	CB Rank (Hub)
Therapeutics Early Stage Companies With More Than 10 Employees	50,255
Therapeutics Early Stage Companies With Less Than $500M in Revenue	47,826
Southern US Early Stage Companies With Fewer Than 50 Employees	35,239
Southern US Biotechnology Companies	2,494
Southern US Startups Founded in 2022	57,157
Greater Philadelphia Area Startups	34,111
United States Therapeutics Companies with Early Stage Venture Funding	42,133
Southern US Early Stage Companies With Fewer Than 100 Employees	31,075
East Coast Health Care Companies with Early Stage Venture Funding	45,728
Therapeutics Early Stage Companies With Less Than $50M in Revenue	48,636